PE-backed Medline’s H1 sales hit $13.5bn ahead of potential $5bn IPO
Medline, the medical supplies manufacturer backed by Blackstone, Carlyle Group, and Hellman & Friedman, has reported net sales of approximately $13.5bn in the first half of 2025, up nearly 10% from the same period last year, according to a report by Bloomberg.